Frank Po-Yen Lin

14PUBLICATIONS
66CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer geneticsHaematological tumoursRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 10, 2026
Enhancing Outcome Measurement in Oncology Clinical Trials Through Artificial Intelligence: A Scoping Review.

|Jun 16, 2026
Time-to-progression ratio as a potential study endpoint in early-phase oncology trials: pooled analysis of phase II trials from the Australian MoST program.

|May 26, 2026
Whole genome sequencing in oesophageal adenocarcinoma unmasks potential precision therapies.

|Jan 02, 2026
A Phase 2 Study of Eribulin in Patients with Metastatic Angiosarcoma and Epithelioid Hemangioendothelioma.

Gregory M Cote, Mason Aberoumand, Edwin Choy

|Apr 16, 2025
Clinical Impact of Somatic Genomic Variants of Oncogenes and Tumor Suppressor Genes in Previously Treated Advanced Non-Small Cell Lung Cancer.

Deborah Di-Xin Zhou, Janene Dalrymple, Danielle Klingberg

|Sep 09, 2024
A signal-seeking phase 2 study of Trastuzumab emtansine in tumours harbouring HER2 amplification or mutation.

Subotheni Thavaneswaran, Frank Lin, John P Grady

Pageof 3

Frequent Collaborators

6 joint publications

Robert John Simes

5 joint publications

David Thomas

4 joint publications

Subotheni Thavaneswaran

3 joint publications

Mandy L Ballinger